Vega Clinic
Vega Clinic
タイ, バンコク
| タイ | トルコ | オーストリア | |
| 血漿交換術 | から $2,200 / 74,800฿ | から $1,200 / 40,800฿ | から $2,000 / 68,000฿ |
| 脊髄幹細胞移植術 | から $25,000 / 850,000฿ | から $30,000 / 1,020,000฿ | から $60,000 / 2,040,000฿ |
| 幹細胞療法 | から $1,800 / 61,200฿ | から $4,675 / 158,950฿ | から $8,500 / 289,000฿ |
Board-certified physiatrist (Diplomate of the Thai Board of Rehabilitation Medicine, 2023). Head of Rehabilitation at King Mongkut Chaokhunthahan Hospital. CEO and Founder of PYONG Rehabilitation Group since 2023.
Clinical focus: neurorehabilitation, geriatric rehabilitation, and chronic pain. Uses robotics and wearable exoskeleton gait training. Performs ultrasound-guided procedures and advanced laser and radiofrequency therapies.
Principal Investigator of a pilot randomized controlled trial on wearable exoskeleton gait training in subacute stroke. Presented to the Royal College of Physiatrists of Thailand in 2023. Instructor at KMITL since 2020.
Completed Rehabilitation Medicine residency at Chulalongkorn University in 2023. Earned an MD in 2017. Runs a public health platform with over 100,000 followers. Hosted PYONG SUMMIT in 2024 with over 200 attendees. Honors include nominee for Quality Person of the Year 2025 and First Prize in the Ananda Mahidol Pin Design in 2016.
Dr. Tara Rak-areekul is a neurologist focused on cognitive neurology. She is a fellow at King Chulalongkorn Memorial Hospital. She completed her neurology residency there and served as Chief of Academic in 2023. She holds an MD from Chulalongkorn University (Second Class Honors) and a Higher Graduate Diploma in Clinical Sciences. She is certified in NIHSS (2022) and the Thai Stroke Society Acute Stroke Treatment Course.
Key achievements include first rank in the National Formative Neurological Exam (2023). She won the Epilepsy Quiz Tournament (2023). She was first runner-up at the Neurology Tournaments at NST Midyear 2023 and the Chula Neuroscience Forum 2022. Her research includes AAIC poster presentations (2024, 2025). Ongoing work covers Alzheimer’s biomarkers (MDS‑OAβ and p‑tau217), the Thai clinical adaptation of HippoCamera, and a chapter on behavioral and psychological symptoms of dementia (BPSD).
Primary ALS treatment in Thailand focuses on multidisciplinary care at JCI-accredited facilities in Bangkok. Patients access FDA-approved medications like Riluzole alongside supportive therapies for respiratory and motor management. Modern protocols often integrate neurorehabilitation with advanced technologies like robotic gait training and mesenchymal stem cell applications.
Bookimed Expert Insight: While many search for experimental stem cell treatments, the real value in Thailand lies in its neurorehabilitation infrastructure. Facilities like Bumrungrad International Hospital serve over 500,000 international patients annually. They combine high-end technology with intensive physical therapy. Choosing a package that includes multiple nights of hospitalization allows for better initial monitoring of drug tolerance.
Patient Consensus: Patients emphasize the need to verify stem cell claims and suggest focusing on palliative support like ventilation. They recommend consulting neurologists at large private hospitals because these centers match international standards for standard ALS medication and nutrition support.
Stem cell therapy for ALS in Thailand aims to slow disease progression and improve quality of life. Clinics utilize mesenchymal stem cells for their neuroprotective properties. While considered experimental, these treatments are available at JCI-accredited facilities in Bangkok using intravenous and intrathecal delivery methods.
Bookimed Expert Insight: Success in Thailand often depends on combining cell therapy with intensive rehabilitation. Our data shows specialized centers like PYONG Rehabilitation Group focus on robotic gait training and neurorehabilitation. Choosing centers that integrate these technologies rather than standalone cell injections often leads to better functional stability. Dr. Kantaphong Thongrong at PYONG specifically uses wearable exoskeletons to maintain mobility during the treatment window.
Patient Consensus: Patients note that while the treatment may offer a temporary boost in energy, it is vital to manage expectations. Many stress the importance of following a strict neurorehabilitation routine afterward to maintain any motor function improvements gained during the trip.
Leading Thai hospitals like Bumrungrad International and Chulalongkorn Memorial provide recognized ALS care through specialized neuroscience departments. These facilities offer multidisciplinary support including neurology, rehabilitation, and palliative services. JCI-accredited centers in Bangkok utilize advanced imaging and international protocols to manage neurodegenerative symptoms.
Bookimed Expert Insight: While many search for experimental therapies, the real value in Thailand is the recovery infrastructure. Specialized providers like PYONG Rehabilitation Group focus on robotic gait training and hydrodissection. These advanced therapies help maintain mobility longer than standard physical therapy alone. This infrastructure is often more accessible in Bangkok than in many Western cities.
Patient Consensus: Patients note that navigating Bangkok traffic with limited mobility is difficult. Many suggest organizing home-based physiotherapy or choosing hospitals with inclusive transfers to minimize physical strain.
International patients choose Thailand for ALS management to access mesenchymal stem cell (MSC) therapies often unavailable in Western countries. Facilities like Bumrungrad International Hospital combine JCI-accredited neurology with advanced robotics. Many programs integrate neurorehabilitation, wearable exoskeleton training, and specialist-led palliative care protocols.
Bookimed Expert Insight: While many seek Thailand for experimental stem cell infusions, the real value lies in the integrated neurorehabilitation. Dr. Kantaphong Thongrong at PYONG Rehabilitation Group leads clinical use of wearable exoskeletons. This robotic gait training is rarely bundled with regenerative treatments elsewhere. Patients should prioritize clinics that offer these physical sessions alongside MSC therapy to maximize mobility outcomes.
Patient Consensus: Patients value Thailand for compassionate and low-stress palliative support. However, they strongly recommend verifying any clinic's success claims against international clinical trial databases before traveling for experimental stem cell procedures.